title: Starring TREK-1: the next generation of vascular K+ channels.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Bryan
authors.forename: Biny K
authors.initials: BK
authors.lastname: Joseph
authors.forename: Eric
authors.initials: E
authors.lastname: Lloyd
authors.forename: Nancy J
authors.initials: NJ
authors.lastname: Rusch
mesh_terms: D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects; D002545:Brain Ischemia / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D002339:Carotid Arteries / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D002531:Cerebellum / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects*; D017078:Laser-Doppler Flowmetry; D051379:Mice; D018345:Mice, Knockout; D024683:Potassium Channels, Tandem Pore Domain / Q000096:biosynthesis* / Q000172:deficiency; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*; D017962:alpha-Linolenic Acid / Q000494:pharmacology*
chemical_list: D024683:Potassium Channels, Tandem Pore Domain; D014665:Vasodilator Agents; C103742:potassium channel protein TREK-1; D017962:alpha-Linolenic Acid